Sponsor:
University of Alberta
Code:
NCT05058612
Conditions
Vasoplegia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Midodrine
Placebo
Brief summary:
Conditions
Vasoplegia
Study ID
NCT05058612
Start date
Mar 22, 2021
Status verified date
Jan, 2026
Completion date
Feb, 2028
Anticipated
Primary completion date
Mar, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
870 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Midodrine
placebo comparator: Placebo
Interventions
Midodrine
Placebo
Primary outcome measure
Central contacts
Locations
University of Alberta Hospital
Recruiting
Edmonton, Alberta, Canada, T5R 0T1
Contacts
Sponsor
University of Alberta
Last update posted
Jan 20, 2026
Last verified
Jan, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alberta on 2026-01-20.